Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Once reconstituted, use within the timeframe specified by your pharmacy typically 28 days
This copper peptide gene regulation manifests in several clinically significant ways: Downregulation of Pro-Inflammatory Genes: It actively suppresses genes associated with inflammation, such as those in the IL-6 and NF-B pathways, which are major drivers of cellular aging
CJC-1295 with DAC includes a drug-affinity-complex modification that binds albumin and extends activity
Manufactured under strict quality controls and tested by independent labs supplied exclusively for laboratory use
Mt vi nghin cu ch ra rng, hm lng Glutathione trong thn thp hn nhng bnh nhn suy thn cp
Important Caveats About the Research Several important limitations should be acknowledged when reviewing the EpitalON literature: The majority of published studies originate from Khavinson's research group or closely affiliated laboratories Independent replication outside Russia has been limited, though the 2025 Biogerontology study represents a notable exception Human clinical data remains sparse, consisting mainly of small studies from one research group Most research has used injectable EpitalON, not oral formulations The peptide is not approved as a medicine in the UK, EU, or US How EpitalON Capsules Are Typically Taken Research Protocol Context The research literature commonly references cycles of 10-20 days at 5-10mg daily, repeated periodically (such as once or twice yearly)
US$ 25.73
US$ 21.61
US$ 23.79
